BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 28614770)

  • 1. Transcription factor GATA3 expression is induced by GLS2 overexpression in a glioblastoma cell line but is GLS2-independent in patient-derived glioblastoma.
    Majewska E; Rola R; Barczewska M; Marquez J; Albrecht J; Szeliga M
    J Physiol Pharmacol; 2017 Apr; 68(2):209-214. PubMed ID: 28614770
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Opposing roles of glutaminase isoforms in determining glioblastoma cell phenotype.
    Szeliga M; Albrecht J
    Neurochem Int; 2015 Sep; 88():6-9. PubMed ID: 25529918
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Downregulation of GLS2 in glioblastoma cells is related to DNA hypermethylation but not to the p53 status.
    Szeliga M; Bogacińska-Karaś M; Kuźmicz K; Rola R; Albrecht J
    Mol Carcinog; 2016 Sep; 55(9):1309-16. PubMed ID: 26258493
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Silencing of GLS and overexpression of GLS2 genes cooperate in decreasing the proliferation and viability of glioblastoma cells.
    Szeliga M; Bogacińska-Karaś M; Różycka A; Hilgier W; Marquez J; Albrecht J
    Tumour Biol; 2014 Mar; 35(3):1855-62. PubMed ID: 24096582
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glutaminase isoforms expression switches microRNA levels and oxidative status in glioblastoma cells.
    de Los Santos-Jiménez J; Campos-Sandoval JA; Márquez-Torres C; Urbano-Polo N; Brøndegaard D; Martín-Rufián M; Lobo C; Peñalver A; Gómez-García MC; Martín-Campos J; Cardona C; Castilla L; da Costa Souza F; Cheng T; Segura JA; Alonso FJ; Curi R; Colquhoun A; DeBerardinis RJ; Márquez J; Matés JM
    J Biomed Sci; 2021 Feb; 28(1):14. PubMed ID: 33610185
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transfection with GLS2 Glutaminase (GAB) Sensitizes Human Glioblastoma Cell Lines to Oxidative Stress by a Common Mechanism Involving Suppression of the PI3K/AKT Pathway.
    Majewska E; Márquez J; Albrecht J; Szeliga M
    Cancers (Basel); 2019 Jan; 11(1):. PubMed ID: 30669455
    [No Abstract]   [Full Text] [Related]  

  • 7. Liver-Type Glutaminase GLS2 Is a Druggable Metabolic Node in Luminal-Subtype Breast Cancer.
    Lukey MJ; Cluntun AA; Katt WP; Lin MJ; Druso JE; Ramachandran S; Erickson JW; Le HH; Wang ZE; Blank B; Greene KS; Cerione RA
    Cell Rep; 2019 Oct; 29(1):76-88.e7. PubMed ID: 31577957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Both GLS silencing and GLS2 overexpression synergize with oxidative stress against proliferation of glioma cells.
    Martín-Rufián M; Nascimento-Gomes R; Higuero A; Crisma AR; Campos-Sandoval JA; Gómez-García MC; Cardona C; Cheng T; Lobo C; Segura JA; Alonso FJ; Szeliga M; Albrecht J; Curi R; Márquez J; Colquhoun A; Deberardinis RJ; Matés JM
    J Mol Med (Berl); 2014 Mar; 92(3):277-90. PubMed ID: 24276018
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mammalian glutaminase Gls2 gene encodes two functional alternative transcripts by a surrogate promoter usage mechanism.
    Martín-Rufián M; Tosina M; Campos-Sandoval JA; Manzanares E; Lobo C; Segura JA; Alonso FJ; Matés JM; Márquez J
    PLoS One; 2012; 7(6):e38380. PubMed ID: 22679499
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Nuclear Translocation of Glutaminase GLS2 in Human Cancer Cells Associates with Proliferation Arrest and Differentiation.
    López de la Oliva AR; Campos-Sandoval JA; Gómez-García MC; Cardona C; Martín-Rufián M; Sialana FJ; Castilla L; Bae N; Lobo C; Peñalver A; García-Frutos M; Carro D; Enrique V; Paz JC; Mirmira RG; Gutiérrez A; Alonso FJ; Segura JA; Matés JM; Lubec G; Márquez J
    Sci Rep; 2020 Feb; 10(1):2259. PubMed ID: 32042057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. MicroRNA-153 regulates glutamine metabolism in glioblastoma through targeting glutaminase.
    Liu Z; Wang J; Li Y; Fan J; Chen L; Xu R
    Tumour Biol; 2017 Feb; 39(2):1010428317691429. PubMed ID: 28218035
    [TBL] [Abstract][Full Text] [Related]  

  • 12. GLS2 is protumorigenic in breast cancers.
    Dias MM; Adamoski D; Dos Reis LM; Ascenção CFR; de Oliveira KRS; Mafra ACP; da Silva Bastos AC; Quintero M; de G Cassago C; Ferreira IM; Fidelis CHV; Rocco SA; Bajgelman MC; Stine Z; Berindan-Neagoe I; Calin GA; Ambrosio ALB; Dias SMG
    Oncogene; 2020 Jan; 39(3):690-702. PubMed ID: 31541193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Structure and activation mechanism of the human liver-type glutaminase GLS2.
    Ferreira IM; Quesñay JEN; Bastos AC; Rodrigues CT; Vollmar M; Krojer T; Strain-Damerell C; Burgess-Brown NA; von Delft F; Yue WW; Dias SM; Ambrosio AL
    Biochimie; 2021 Jun; 185():96-104. PubMed ID: 33746066
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FOXC2 often overexpressed in glioblastoma enhances proliferation and invasion in glioblastoma cells.
    Li W; Fu X; Liu R; Wu C; Bai J; Xu Y; Zhao Y; Xu Y
    Oncol Res; 2013; 21(2):111-20. PubMed ID: 24406047
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of glutaminase 2 and neutrophil cytosolic factor 2 is associated with the poor prognosis of glioblastoma.
    Wang D; Liu J; Chen Q; Yang R; Jiang Q
    Biomark Med; 2020 Nov; 14(16):1585-1597. PubMed ID: 33179520
    [No Abstract]   [Full Text] [Related]  

  • 16. Glutaminases in brain: Multiple isoforms for many purposes.
    Campos-Sandoval JA; Martín-Rufián M; Cardona C; Lobo C; Peñalver A; Márquez J
    Neurochem Int; 2015 Sep; 88():1-5. PubMed ID: 25837287
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of Wnt5a in the proliferation of human glioblastoma cells.
    Yu JM; Jun ES; Jung JS; Suh SY; Han JY; Kim JY; Kim KW; Jung JS
    Cancer Lett; 2007 Nov; 257(2):172-81. PubMed ID: 17709179
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of Gls and Gls2 glutaminase isoforms in astrocytes.
    Cardona C; Sánchez-Mejías E; Dávila JC; Martín-Rufián M; Campos-Sandoval JA; Vitorica J; Alonso FJ; Matés JM; Segura JA; Norenberg MD; Rama Rao KV; Jayakumar AR; Gutiérrez A; Márquez J
    Glia; 2015 Mar; 63(3):365-82. PubMed ID: 25297978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Discovery of selective inhibitors of Glutaminase-2, which inhibit mTORC1, activate autophagy and inhibit proliferation in cancer cells.
    Lee YZ; Yang CW; Chang HY; Hsu HY; Chen IS; Chang HS; Lee CH; Lee JC; Kumar CR; Qiu YQ; Chao YS; Lee SJ
    Oncotarget; 2014 Aug; 5(15):6087-101. PubMed ID: 25026281
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Glutaminase 2 is a novel negative regulator of small GTPase Rac1 and mediates p53 function in suppressing metastasis.
    Zhang C; Liu J; Zhao Y; Yue X; Zhu Y; Wang X; Wu H; Blanco F; Li S; Bhanot G; Haffty BG; Hu W; Feng Z
    Elife; 2016 Jan; 5():e10727. PubMed ID: 26751560
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.